Sources: CBC
Pfizer and its German partner BioNTech begin a clinical trial to test the safety and immune response of their Omicron-specific COVID-19 vaccine for adults under the age of 55 years. 2022-01-25
The U.S. CDC approves the Pfizer–BioNTech COVID-19 vaccine for children aged 5 and 11 years old. 2021-11-2
Prime Minister Justin Trudeau says Pfizer will double the amounts of vaccine that are being shipped to Canada. He also announces that the Canadian Red Cross will be deployed to Ontario to help with COVID-19 vaccinations. 2021-04-16
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Chile begins its vaccination campaign against COVID-19 after the arrival of 10,000 doses of Pfizer-BioNTech vaccine to the country. 2020-12-24
Mexico begins vaccinations with the Pfizer-BioNTech vaccine. An intensive care unit nurse in Mexico City becomes the first person in the country to receive the vaccine. 2020-12-24
Iraq signs a preliminary deal to receive 1.5 million doses of the Pfizer-BioNTech vaccine Tozinameran. Ministry of Health spokesman Seif al-Badr says troops and the elderly will be prioritized for vaccinations. 2020-12-22
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7
Pfizer and BioNTech apply for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases. 2020-11-20
Pfizer and BioNTech say that their potential vaccine is 90% effective at preventing COVID-19 infections. 2020-11-9